YTHDC2
3'-5' RNA helicase YTHDC2
Also known as: DKFZp564A186, FLJ10053, FLJ2194, YTDC2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H6S0
- Gene
- YTHDC2
- Ensembl
- ENSG00000047188
- Chromosome
- 5
- Canonical length
- 1430 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Cytoplasmic bodies
OverviewNCBI Gene
This gene encodes a member of the DEAH (Asp-Glu-Ala-His) subfamily of proteins, part of the DEAD (Asp-Glu-Ala-Asp) box family of RNA helicases. The encoded protein binds to N6-methyladenosine, a common modified RNA nucleotide that is enriched in the stop codons and 3' UTRs of eukaryotic messenger RNAs. Binding of proteins to this modified nucleotide may regulate mRNA translation and stability. This gene may be associated with susceptibility to pancreatic cancer in human patients, and knockdown of this gene resulted in reduced proliferation in a human liver cancer cell line. [provided by RefSeq, Sep 2016]
Canonical amino-acid sequenceUniProt
1430 residues, UniProt reviewed canonical sequence.
>Q9H6S0|YTHDC2
1 MSRPSSVSPR QPAPGGGGGG GPSPCGPGGG GRAKGLKDIR IDEEVKIAVN IALERFRYGD
61 QREMEFPSSL TSTERAFIHR LSQSLGLVSK SKGKGANRYL TVKKKDGSET AHAMMTCNLT
121 HNTKHAVRSL IQRFPVTNKE RTELLPKTER GNVFAVEAEN REMSKTSGRL NNGIPQIPVK
181 RGESEFDSFR QSLPVFEKQE EIVKIIKENK VVLIVGETGS GKTTQIPQFL LDDCFKNGIP
241 CRIFCTQPRR LAAIAVAERV AAERRERIGQ TIGYQIRLES RVSPKTLLTF CTNGVLLRTL
301 MAGDSTLSTV THVIVDEVHE RDRFSDFLLT KLRDLLQKHP TLKLILSSAA LDVNLFIRYF
361 GSCPVIYIQG RPFEVKEMFL EDILRTTGYT NKEMLKYKKE KQQEEKQQTT LTEWYSAQEN
421 SFKPESQRQR TVLNVTDEYD LLDDGGDAVF SQLTEKDVNC LEPWLIKEMD ACLSDIWLHK
481 DIDAFAQVFH LILTENVSVD YRHSETSATA LMVAAGRGFA SQVEQLISMG ANVHSKASNG
541 WMALDWAKHF GQTEIVDLLE SYSATLEFGN LDESSLVQTN GSDLSAEDRE LLKAYHHSFD
601 DEKVDLDLIM HLLYNICHSC DAGAVLIFLP GYDEIVGLRD RILFDDKRFA DSTHRYQVFM
661 LHSNMQTSDQ KKVLKNPPAG VRKIILSTNI AETSITVNDV VFVIDSGKVK EKSFDALNFV
721 TMLKMVWISK ASAIQRKGRA GRCRPGICFR LFSRLRFQNM LEFQTPELLR MPLQELCLHT
781 KLLAPVNCPI ADFLMKAPEP PPALIVRNAV QMLKTIDAMD TWEDLTELGY HLADLPVEPH
841 LGKMVLCAVV LKCLDPILTI ACTLAYRDPF VLPTQASQKR AAMLCRKRFT AGAFSDHMAL
901 LRAFQAWQKA RSDGWERAFC EKNFLSQATM EIIIGMRTQL LGQLRASGFV RARGGGDIRD
961 VNTNSENWAV VKAALVAGMY PNLVHVDREN LVLTGPKEKK VRFHPASVLS QPQYKKIPPA
1021 NGQAAAIKAL PTDWLIYDEM TRAHRIANIR CCSAVTPVTI LVFCGPARLA SNALQEPSSF
1081 RVDGIPNDSS DSEMEDKTTA NLAALKLDEW LHFTLEPEAA SLLLQLRQKW HSLFLRRMRA
1141 PSKPWSQVDE ATIRAIIAVL STEEQSAGLQ QPSGIGQRPR PMSSEELPLA SSWRSNNSRK
1201 SSADTEFSDE CTTAERVLMK SPSPALHPPQ KYKDRGILHP KRGTEDRSDQ SSLKSTDSSS
1261 YPSPCASPSP PSSGKGSKSP SPRPNMPVRY FIMKSSNLRN LEISQQKGIW STTPSNERKL
1321 NRAFWESSIV YLVFSVQGSG HFQGFSRMSS EIGREKSQDW GSAGLGGVFK VEWIRKESLP
1381 FQFAHHLLNP WNDNKKVQIS RDGQELEPLV GEQLLQLWER LPLGEKNTTDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against YTHDC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- retina: 17 nTPM
- parathyroid gland: 15 nTPM
- testis: 14 nTPM
- lymph node: 13 nTPM
- cerebellum: 12 nTPM
- tonsil: 12 nTPM
Single-cell type
- pituicytes/fscs: 238 nCPM
- microglia: 201 nCPM
- myonuclei: 198 nCPM
- rod photoreceptor cells: 194 nCPM
- lactotrophs: 194 nCPM
- somatotrophs: 181 nCPM
Immune cell
- memory B-cell: 7.3 nTPM
- naive B-cell: 5.1 nTPM
- NK-cell: 4.3 nTPM
- plasmacytoid DC: 3.6 nTPM
- naive CD4 T-cell: 3.4 nTPM
- non-classical monocyte: 3.4 nTPM
Brain region
- cerebellum: 23 nTPM
- choroid plexus: 21 nTPM
- white matter: 19 nTPM
- cerebral cortex: 18 nTPM
- midbrain: 17 nTPM
- pons: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.13
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.33
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- germline cell cycle switching, mitotic to meiotic cell cycle
- host-mediated activation of viral genome replication
- meiotic cell cycle
- oocyte development
- response to interleukin-1
- response to tumor necrosis factor
- spermatid development
Molecular functions
- 3'-5' RNA helicase activity
- ATP binding
- ATP hydrolysis activity
- ATP-dependent activity, acting on RNA
- helicase activity
- N6-methyladenosine-containing RNA reader activity
- RNA binding
- RNA polymerase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- R3H domain
- Helicase, C-terminal domain-like
- Ankyrin repeat
- YTH domain
- Helicase-associated domain
- DEAD/DEAH-box helicase domain
- DEAD-box helicase, OB fold
- Helicase superfamily 1/2, ATP-binding domain
- P-loop containing nucleoside triphosphate hydrolase
- Ankyrin repeat-containing domain superfamily
- R3H domain superfamily
- Helicase associated domain (HA2), winged-helix domain
- RNA helicase, C-terminal domain
- DEAD/DEAH box helicase
- Helicase conserved C-terminal domain
- R3H domain
- YT521-B-like domain
- Helicase associated domain (HA2), winged-helix
- Oligonucleotide/oligosaccharide-binding (OB)-fold
- Helicase associated domain (HA2), ratchet-like
- C-terminal domain in RNA helicases
- DExH-box ATP-dependent RNA helicase, R3H domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of YTHDC2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads YTHDC2 as an antibody target. Whether an autoantibody or antibody against YTHDC2 could matter depends on whether native YTHDC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
YTHDC2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label YTHDC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...